search
Back to results

LapBand Adjustment to Improve Early Weight Loss

Primary Purpose

Obesity

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
EndoFLIP device (FDA Device Listing Number : D091203)
Sponsored by
Crospon
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obesity focused on measuring Gastric Band, LapBand, Bariatric Surgery

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients undergoing gastric band surgery
  • Over 18 years of age

Exclusion Criteria:

  • Actively bleeding varices

Sites / Locations

  • Specialty Surgery of Fort Worth

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Stoma Adjustment at Surgery

Historic

Arm Description

The first band adjustment will be made at surgery versus historical controls where the adjustment is not made for 3-4 weeks post-surgery. EndoFLIP device (FDA Device Listing Number : D091203)will be used to make the adjustment.

Weight loss profile over time for 50 patients in the first 12 months after surgery as derived from historic control records. Band adjustments are made in a heuristic fashion during the year after surgery using the experience of surgeon alone

Outcomes

Primary Outcome Measures

%Excess Weight Loss 4-6 Weeks After Surgery (Large and Small Bands)
%Excess Weight Loss 4-6 Weeks After Surgery (Small Bands Only)
% Excess Weight Loss 12 Months After Surgery (Large and Small Bands)
% Excess Weight Loss 12 Months After Surgery (Small Bands Only)

Secondary Outcome Measures

Number of Band Adjustments Required in the First Year After Surgery

Full Information

First Posted
January 30, 2010
Last Updated
April 4, 2013
Sponsor
Crospon
search

1. Study Identification

Unique Protocol Identification Number
NCT01060592
Brief Title
LapBand Adjustment to Improve Early Weight Loss
Official Title
Effect on Early Weight Loss by Adjusting Gastric Band During Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
April 2013
Overall Recruitment Status
Completed
Study Start Date
October 2009 (undefined)
Primary Completion Date
December 2010 (Actual)
Study Completion Date
March 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Crospon

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Subjects having a gastric band fitted will have the first band adjustment done at surgery. The stoma will be set to 7mm using the EndoFLIP system to measure stoma size. Thereafter, band adjustments will be made using an adjustment chart, created at surgery, which shows stoma size versus band fill, to make adjustments in the normal follow-up visits. It is hypothesized that an early adjustment at surgery will promote earlier weight loss, and result in fewer band adjustments being required in the first year after surgery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity
Keywords
Gastric Band, LapBand, Bariatric Surgery

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
35 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Stoma Adjustment at Surgery
Arm Type
Experimental
Arm Description
The first band adjustment will be made at surgery versus historical controls where the adjustment is not made for 3-4 weeks post-surgery. EndoFLIP device (FDA Device Listing Number : D091203)will be used to make the adjustment.
Arm Title
Historic
Arm Type
No Intervention
Arm Description
Weight loss profile over time for 50 patients in the first 12 months after surgery as derived from historic control records. Band adjustments are made in a heuristic fashion during the year after surgery using the experience of surgeon alone
Intervention Type
Device
Intervention Name(s)
EndoFLIP device (FDA Device Listing Number : D091203)
Intervention Description
The EndoFLIP balloon catheter will be introduced to the band and used to permit the band stoma size to be adjusted to 7mm.
Primary Outcome Measure Information:
Title
%Excess Weight Loss 4-6 Weeks After Surgery (Large and Small Bands)
Time Frame
4-6 weeks post surgery
Title
%Excess Weight Loss 4-6 Weeks After Surgery (Small Bands Only)
Time Frame
4-6 weeks post surgery
Title
% Excess Weight Loss 12 Months After Surgery (Large and Small Bands)
Time Frame
12m post surgery
Title
% Excess Weight Loss 12 Months After Surgery (Small Bands Only)
Time Frame
12m post surgery
Secondary Outcome Measure Information:
Title
Number of Band Adjustments Required in the First Year After Surgery
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients undergoing gastric band surgery Over 18 years of age Exclusion Criteria: Actively bleeding varices
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Robert G Snow, DO FACOS
Organizational Affiliation
AIGB
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
John O'Dea, PhD
Organizational Affiliation
Crospon
Official's Role
Study Director
Facility Information:
Facility Name
Specialty Surgery of Fort Worth
City
Hurst
State/Province
Texas
ZIP/Postal Code
76054
Country
United States

12. IPD Sharing Statement

Citations:
Citation
Snow RG, O'Dea J. Does Intraoperative Gastric Band Adjustment to a Targeted Stoma Size Improve Weight Loss? One-year Results of a Feasibility Trial Bariatric Times. 2012;9(1):10-12.
Results Reference
result

Learn more about this trial

LapBand Adjustment to Improve Early Weight Loss

We'll reach out to this number within 24 hrs